Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
Top Cited Papers
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (3) , 650-654
- https://doi.org/10.1016/j.ygyno.2004.01.029
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Quality of Complication Reporting in the Surgical LiteratureAnnals of Surgery, 2002
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Identification of Prognostic Factors in Advanced Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian CarcinomaGynecologic Oncology, 2000
- Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective StudyGynecologic Oncology, 1998
- Stage IV Ovarian Cancer: Impact of Surgical Debulking1Gynecologic Oncology, 1997
- The cavitational ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1992
- AnnouncementGynecologic Oncology, 1986
- Prognostic factors in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986